Raise Impact completed the acquisition of a majority stake in Happyneuron.

Raise Impact, the European small-mid cap strategy of the RAISE Group, completed the acquisition of a majority stake in Happyneuron, a company specialized in cognitive assessment and rehabilitation. Financial terms were not disclosed. “We are delighted to partner with Édouard Blanchard and the Happyneuron team for this new phase of their development. This investment perfectly reflects RAISE Impact’s mission: to support high-growth SMEs that bring concrete solutions to environmental and societal challenges, with a strong ambition for international expansion. We look forward to supporting this innovative company, at the intersection of scientific research and healthcare, in the execution of an ambitious growth plan, leveraging the full strength and expertise of the RAISE ecosystem,” Aglaé Touchard Le Drian and Serge Bedrossian, Raise Impact Co-Heads.